Bioforce Nanosciences Holdings annual gross margin
2017
2018
2019
Bioforce Nanosciences Holdings Gross Margin Growth & History (BFNH)
Bioforce Nanosciences Holdings's gross margin was 24.53% for fiscal 2019.
View full Bioforce Nanosciences Holdings company overviewBioforce Nanosciences Holdings annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2019 | 2019-12-31 | 24.53% | −4.07 pp |
| 2018 | 2018-12-31 | 28.60% | +0.71 pp |
| 2017 | 2017-12-31 | 27.89% | — |
Bioforce Nanosciences Holdings quarterly gross margin
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q4.19
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2019 | 2019-12-31 | 100.00% | +71.12 pp |
| Q3 2019 | 2019-09-30 | 28.88% | +0.89 pp |
| Q2 2019 | 2019-06-30 | 15.88% | — |
| Q1 2019 | 2019-03-31 | 28.89% | — |
| Q3 2018 | 2018-09-30 | 28.88% | — |
| Q2 2018 | 2018-06-30 | 27.99% | — |
Bioforce Nanosciences Holdings gross margin trends
Across the available reported history, Bioforce Nanosciences Holdings's gross margin decreased from 28.60% to 24.53%, a change of −4.07 percentage points. The latest reported quarter, Q4 2019, shows 100.00%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioforce Nanosciences Holdings filings at SEC.gov ↗